Page last updated: 2024-11-02

pamidronate and Mastocytosis, Systemic

pamidronate has been researched along with Mastocytosis, Systemic in 3 studies

Mastocytosis, Systemic: A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.

Research Excerpts

ExcerptRelevanceReference
"Systemic mastocytosis is characterised by proliferation of mast cells and infiltration of organs."1.33Involvement of the jaw bones in systemic mastocytosis. ( Castling, B; Myers, B; Smith, AT, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Myers, B2
Castling, B1
Smith, AT1
Laroche, M1
Bret, J1
Brouchet, A1
Mazières, B1

Other Studies

3 other studies available for pamidronate and Mastocytosis, Systemic

ArticleYear
Comment on systemic mastocytosis study.
    British journal of haematology, 2003, Volume: 121, Issue:3

    Topics: Adult; Diphosphonates; Humans; Interferon-alpha; Male; Mastocytosis, Systemic; Middle Aged; Pain; Pa

2003
Involvement of the jaw bones in systemic mastocytosis.
    The British journal of oral & maxillofacial surgery, 2006, Volume: 44, Issue:2

    Topics: Adult; Bone Density Conservation Agents; Diphosphonates; Histamine H1 Antagonists; Humans; Jaw Neopl

2006
Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis.
    Clinical rheumatology, 2007, Volume: 26, Issue:2

    Topics: Adult; Aged; Anti-Inflammatory Agents; Bone Density; Bone Marrow Cells; Bone Remodeling; Diphosphona

2007